FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Video shows masked robbers crash car through jewelry store entrance, steal owner’s gun in brazen heist

Barack and Michelle Obama slam ICE after Minneapolis shooting, urge accountability

Tim Walz compares Minnesota ICE actions to Holocaust and Anne Frank: ‘Hiding in their houses’

ICE says violent mob helped criminal escape and left ICE agent permanently maimed

Iran may have killed over 30,000 protesters in two days: Report

Dems silent on Minnesota church disruption after pressing Bondi to use FACE Act on pro-lifers

Carney pushes back on Trump’s 100% tariff threat over China trade deals with Canada amid tensions

Here Are the Worst Countries on Earth for Christian Persecution

Texas cult in crosshairs of killer mom’s bathtub slayings case as questions hang over family horror

Popular Potato Product Faces Recall in 26 States

Can Trump Really Denaturalize Somalis En Masse?

Tim Walz Was the Most Scandal-Plagued Governor Running in 2026: Katie Hobbs Just Stole That Title

Mamdani announces remote school day due to dangerous winter storm conditions

GOP lawmaker renews oversight hearing request of DHS agencies following fatal shooting in Minneapolis

Terrible Sign for Midterms: GOP Losing Independents By Massive 22-Point Margin

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”